COMPANY PROFILE

GI INNOVATION

Explore full profile

GI Innovation is a global leader of microbiome drug development

Seoul, South KoreaFounded 2017Biotech & Life Sciences

Valuation $250–500M Last recorded · 2026

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About GI INNOVATION

GI Innovation is a bio venture company focused on the research and development of innovative protein-based drugs. The company operates in the biotechnology sector, serving patients worldwide by creating new bio drugs through structured translational research. GI Innovation leverages its proprietary platform, which includes high throughput screening systems and bispecific antibody programs, to efficiently discover and develop lead products and cell lines. The company primarily targets the global healthcare market, aiming to address unmet medical needs with its novel therapeutic solutions. Its business model revolves around the development and commercialization of patented substances, ensuring exclusive rights to their innovative drugs. Revenue is generated through the sale of these proprietary drugs and potential licensing agreements with other pharmaceutical companies. Key clients include healthcare providers, research institutions, and pharmaceutical companies looking for cutting-edge bio drug solutions.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Seoul, South Korea
Employees: 35
Open positions: 3
Dealroom signal: 40.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Microbiome, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
IPOOther financing	Mar 2023	$206M	$206M	Undisclosed	—
SERIES COther financing	Jun 2021	$143M	$573M	Aju IB Investment · NH Investment & Securities · DAYLI Partners · DS Asset Management	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

GI INNOVATION website traffic

Latest recorded traffic for GI INNOVATION is 42K monthly website visits, down 8.7% over the last three months. GI INNOVATION's team grew 6.1% over the past year.

Latest monthly visits42K 3-month web change-8.7% 1-year team growth+6.1%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

[] 1South Korea, Seoul, Songpa-gu, Munjeong-dong, Songpa-daero, 167 테라타워 · Other · Jul 7, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
DIDIADEMImproves clinicians/patient understanding about risk of Dementia/Alzheimer’s to enable earlier decisions and outcome	London, United Kingdom	Operational	10	$14M	$44M
USUute ScientificDeveloping microbiome science to improve human health	Lohja, Finland	Operational
IKIkarovecBi-functional gene therapies for chronic eye diseases	Norwich, United Kingdom	Operational
PBPlasmaGen BiosciencesPlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy. Headquartered in Bangalore- India	Bengaluru, India	Operational
HSHealthy SkoopCompany dedicated to fighting disease, inflammation and general un-awesomeness	Boulder, United States	Acquired
GEGeneFormaticsBiotechnology company specializing in structural proteomics	San Diego, United States	Operational
MDMebias DiscoveryMebias Discovery holds a game-changing platform to discover next generation	Philadelphia, United States	Operational
PTPendulum TherapeuticsMicrobiome company focused on enabling better patient care through targeted equilibration of human microbiomes	San Francisco, United States	Operational